ArticleInternal and emergency medicine2026
Angiotensin receptor-neprilysin inhibitor versus angiotensin-converting enzyme inhibitor for osteoporosis risk in patients with heart failure.
Wei-Syun Hu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.